Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced that Rinko Ghosh, President and Chief Business Officer, will present an overview of the company pipeline at the 10th Annual ChinaBio Partnering Forum being held April 25-26, 2018, in Suzhou, China.
April 18, 2018
· 1 min read